N-acetyl-beta-D-galacto-hexodialdo-1,5-pyranosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosylceramide

Term ID

CHEBI:132887

Synonyms

beta-D-GalNAc6dH2-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer
beta-D-GalpNAc6dH2-(1->4)-beta-D-Galp-(1->4)-beta-D-Glcp-(1<->1')-Cer
C6 aldehyde asialo GM2
N-[(2S,3R,4E)-1-{[2-acetamido-2-deoxy-beta-D-galacto-hexodialdo-1,5-pyranosyl-(1->4)-beta-D-galactopyranosyl-(1->4)-beta-D-glucopyranosyl]oxy}-3-hydroxyoctadec-4-en-2-yl]alkanamide
N-acetyl-beta-D-galacto-hexodialdo-1,5-pyranosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-N-acylsphing-4-enine

Definition

A glycotriaosylceramide having N-acetyl-beta-D-galacto-hexodialdo-1,5-pyranosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl as the triaosyl component.

References

PMID:512581

Ontology

ChEBI ( EBI )

Relationships

is a type of: glycotriaosylceramide

glycotriaosylceramide Show first 5 Terms

Phenotype

Phenotype resulting from N-acetyl-beta-D-galacto-hexodialdo-1,5-pyranosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosylceramide

Phenotype where environments contain N-acetyl-beta-D-galacto-hexodialdo-1,5-pyranosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosylceramide

Phenotype modified by environments containing N-acetyl-beta-D-galacto-hexodialdo-1,5-pyranosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosylceramide

Human Disease / Model Data